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Abstract
When an acute myocardial infarction (MI) occurs, the heart becomes ischemic. Medical treat-
ments such as stents have improved the recovery process after a MI, but there is still a high risk for
heart failure. Due to the resulting intramyocardial hemorrhage, residual hemoglobin with excess
iron compromises cardiomyocyte (CM) survival. Previous studies suggest that the magnitude of
CM cell death is directly proportional to the level of adverse left ventricular (LV) remodeling.
Mechanistic target of rapamycin (mTOR) is a key downstream signaling pathway that is sufficient
for CM cell survival against iron and responds to insulin, a cardioprotective growth factor. How-
ever, the effect of insulin in excess iron-induced cell death in CMs is not well characterized. Using
H9c2 cardiomyoblasts, originally derived from embryonic rat ventricle cells, the effects of insulin
in CM cell survival against excess iron were examined. The cells were pre-treated with varying
dosages of insulin before applying iron (III) citrate. Cell viability was assessed by Live/Dead
Assay, in which live cells stain with calcein AM (green) and nuclei of dead cells stain with ethid-
ium homodimer-1 (red). In comparison to the amount of cell death caused by iron alone, insulin
decreased dead cell count substantially. The greatest concentration of 1µM of insulin with iron
resulted in a statistical significance of p<0.02 (n=3-4). The results indicate that insulin has the
potential to mediate iron-induced CM death. Understanding the effect of insulin as a combat-
ant of iron-induced cell death with an intramyocardial approach would lead to better therapeutic
preventions of heart failure.
KEYWORDS: Myocardial infarction; LV remodeling; Intramyocardial hemorrhage; Cardiomy-
ocyte; mTOR; Insulin
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ABSTRACT 
When an acute myocardial infarction (MI) occurs, the heart becomes ischemic. Medical 
treatments such as stents have improved the recovery process after a MI, but there is still a high 
risk for heart failure. Due to the resulting intramyocardial hemorrhage, residual hemoglobin with 
excess iron compromises cardiomyocyte (CM) survival. Previous studies suggest that the 
magnitude of CM cell death is directly proportional to the level of adverse left ventricular (LV) 
remodeling. Mechanistic target of rapamycin (mTOR) is a key downstream signaling pathway that 
is sufficient for CM cell survival against iron and responds to insulin, a cardioprotective growth 
factor. However, the effect of insulin in excess iron-induced cell death in CMs is not well 
characterized. Using H9c2 cardiomyoblasts, originally derived from embryonic rat ventricle cells, 
the effects of insulin in CM cell survival against excess iron were examined. The cells were pre-
treated with varying dosages of insulin before applying iron (III) citrate. Cell viability was assessed 
by Live/Dead Assay, in which live cells stain with calcein AM (green) and nuclei of dead cells 
stain with ethidium homodimer-1 (red). In comparison to the amount of cell death caused by iron 
alone, insulin decreased dead cell count substantially. The greatest concentration of 1µM of insulin 
with iron resulted in a statistical significance of p<0.02 (n=3-4). The results indicate that insulin 
has the potential to mediate iron-induced CM death. Understanding the effect of insulin as a 
combatant of iron-induced cell death with an intramyocardial approach would lead to better 
therapeutic preventions of heart failure.  
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